Page last updated: 2024-12-06
light green sf
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Light green SF: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
acid green 5 : An organic sodium salt having 3-[(ethyl{4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}azaniumyl)methyl]benzene-1-sulfonate as the counterion. It is the standard dye in North American for staining collagen and is also used extensively in plant histology. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 21223 |
| CHEBI ID | 87065 |
| SCHEMBL ID | 333260 |
| MeSH ID | M0066615 |
Synonyms (107)
| Synonym |
|---|
| disodium 3-[(ethyl{(1z,4z)-4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}ammonio)methyl]benzenesulfonate |
| fd & c green no. 2 |
| nsc 9619 |
| fd&c green no. 2 |
| zelen svetla sf [czech] |
| benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, disodium salt |
| fd and c green no. 4 |
| ccris 889 |
| ammonium, ethyl(4-(p-(ethyl(m-sulfobenzyl)amino)-alpha-(p-sulfophenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)(m-sulfobenzyl)-, hydroxide, inner salt, disodium salt |
| lichtgruen [german] |
| benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt |
| benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methy lene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt |
| fd&c green no. 2 - aluminum lake |
| zelen kysela f [czech] |
| c.i. 670 |
| einecs 225-906-5 |
| light green fcf yellowish |
| zelen kysela 5 [czech] |
| zelen potravinarska 2 [czech] |
| dihydrogen (ethyl)(4-(p-(ethyl(m-sulphonatobenzyl)amino)-p'-sulphonatobenzhydrylene)cyclohexa-2,5-dien-1-ylidene)(m-sulphonatobenzyl)ammonium, disodium salt |
| d&c green no. 2 |
| my/68 |
| lissamine green sf |
| sulfo green j |
| light green 2gn |
| light green lake |
| c.i. food green 2 |
| light green sfa |
| leather green sf |
| light sf yellowish (biological stain) |
| light green g |
| acid green 5 |
| lissamine lake green sf |
| light green sfd |
| fast acid green n |
| c.i. acid green 5 |
| acilan green sfg |
| light green s |
| lichtgruen |
| light green sf |
| a.f. green no. 2 |
| acidal light green sf |
| fenazo green 7g |
| food green 2 |
| a f green no.2 |
| sumitomo light green sf yellowish |
| pencil green sf |
| merantine green sf |
| fd and c green no. 2-aluminum lake |
| light green fs |
| d and c green no. 4 |
| amacid green g |
| acid brilliant green sf |
| green no. 203 |
| light green yellowish |
| nsc-9619 |
| light green cf |
| 5141-20-8 |
| light green sf yellowish |
| c.i. acid green 5, disodium salt |
| acid green gg |
| L0054 |
| L0141 |
| guinea green 2g |
| zelen svetla sf |
| benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, sodium salt (1:2) |
| hsdb 8009 |
| 3f7bha64z0 , |
| unii-3f7bha64z0 |
| zelen kysela 5 |
| zelen kysela f |
| zelen potravinarska 2 |
| FT-0627852 |
| AKOS015902760 |
| AKOS025310847 |
| light green sf yellowish [mi] |
| midori205 |
| benzenemethanaminium, n-ethyl-n-((1z,4z)-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, disodium salt |
| green no. 205 |
| midori205 [inci] |
| benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methy lene)- 2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt |
| acid brilliant green 5 |
| fd&c green no. 2 (delisted) |
| light green sf [iarc] |
| ci 42095 |
| disodium 3-((ethyl((1z,4z)-4-((4-(ethyl(3-sulphonatobenzyl)amino)phenyl)(4-sulphonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulphonate |
| disodium 3-((ethyl((1z,4z)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate |
| SCHEMBL333260 |
| CHEBI:87065 , |
| disodium 3-[(ethyl{4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}azaniumyl)methyl]benzene-1-sulfonate |
| mfcd00012121 |
| DTXSID8020672 , |
| DB11183 |
| sodium 3-(((e)-ethyl((e)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dienylidene)ammonio)methyl)benzenesulfonate |
| Q6546012 |
| disodium;3-[[n-ethyl-4-[[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]-(4-sulfonatophenyl)methyl]anilino]methyl]benzenesulfonate |
| sodium 3-((ethyl((1e,4e)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate |
| sodium 3-((-ethyl(-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate |
| D91235 |
| sodium3-((-ethyl(-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate |
| AS-83738 |
| n-ethyl-n-(4-((3-sulfophenyl)methyl)amino)-phenyl)-(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium hydroxide inner salt, disodium salt |
| light green sf (iarc) |
| disodium 3-((ethyl(4-((4-(ethyl((3-sulfonatophenyl)methyl)amino)phenyl)(4-sulfonatophenyl)methylidene)cyclohexa-2,5-dien-1-ylidene)azaniumyl)methyl)benzene-1-sulfonate |
| d&c green no. 4 |
| greenglo |
| dtxcid60672 |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " Adverse effects on anterior and posterior segments were evaluated by slit lamp biomicroscopy and ophthalmoscopy." | ( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006) | 0.33 |
| "BPB or LGSF produced no significantly detectable toxic effects on the retina in vivo." | ( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006) | 0.33 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (1)
| Role | Description |
|---|---|
| histological dye | A dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Drug Classes (1)
| Class | Description |
|---|---|
| organic sodium salt | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 36.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (36.84) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.69%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (92.31%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||